9-ING-41
1902
Phase 1 small_molecule terminated
Quick answer
9-ING-41 for Refractory Cancer is a Phase 1 program (small_molecule) at ACTUATE THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACTUATE THERAPEUTICS, INC.
- Indication
- Refractory Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated